Nanoemulsions for Intravenous Drug Delivery

Emulsions have been broadly defined as two immiscible phases dispersed within another (Becher, 2001). In principle, this definition could apply to a number of systems including, but not limited to, gas-in-liquid,...

[1]  P. Mongan,et al.  The anesthetic and physiologic effects of an intravenous administration of a halothane lipid emulsion (5% vol/vol) , 1999, Anesthesia and analgesia.

[2]  J. Hayes,et al.  An experimental study of pulmonary damage associated with intravenous injection of halothane in dogs. , 1970, British journal of anaesthesia.

[3]  J. Israelachvili.  Intermolecular and surface forces , 1985 .

[4]  J. Schulman,et al.  Mechanism of Formation and Structure of Micro Emulsions by Electron Microscopy , 1959 .

[5]  Clarence A. Miller.  Spontaneous Emulsification: Recent Developments with Emphasis on Self-Emulsification , 2005 .

[6]  F. D. D'Auria,et al.  Anticandidal activity of SPA-S-843, a new polyenic drug. , 2000, The Journal of antimicrobial chemotherapy.

[7]  P. Adamson,et al.  Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers. , 2003, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[8]  D. Lu,et al.  VLDL-resembling phospholipid-submicron emulsion for cholesterol-based drug targeting. , 2002, Journal of pharmaceutical sciences.

[9]  P. Diwan,et al.  Biodisposition of PEG-coated lipid microspheres of indomethacin in arthritic rats. , 2005, International journal of pharmaceutics.

[10]  Hoo-Kyun Choi,et al.  Pharmacokinetic and pharmacodynamic evaluation of cyclosporin A O/W-emulsion in rats. , 2002, International journal of pharmaceutics.

[11]  J. Rolland,et al.  Detrimental effect of excess lecithin on the stability of fluorocarbon/lecithin emulsions , 1991 .

[12]  S. B. Tiwari,et al.  Preparation and In Vitro Characterization of Multifunctional Nanoemulsions for Simultaneous MR Imaging and Targeted Drug Delivery , 2006 .

[13]  Jhi-Joung Wang,et al.  Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[14]  O. Mertins,et al.  Spray-dried indomethacin-loaded polyester nanocapsules and nanospheres: development, stability evaluation and nanostructure models. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[15]  W. Higuchi,et al.  Physical degradation of emulsions via the molecular diffusion route and the possible prevention thereof. , 1962, Journal of pharmaceutical sciences.

[16]  Jean-Louis Salager,et al.  SURFACTANT-OIL-WATER SYSTEMS NEAR THE AFFINITY INVERSION PART I: RELATIONSHIP BETWEEN EQUILIBRIUM PHASE BEHAVIOR AND EMULSION TYPE AND STABILITY , 1982 .

[17]  P. Taylor.  Ostwald ripening in emulsions: estimation of solution thermodynamics of the disperse phase. , 2003, Advances in colloid and interface science.

[18]  R. Maranhão,et al.  Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancers , 2006, Cancer Chemotherapy and Pharmacology.

[19]  R. Müller,et al.  SolEmuls-novel technology for the formulation of i.v. emulsions with poorly soluble drugs. , 2004, International journal of pharmaceutics.

[20]  T. Hoar,et al.  Transparent Water-in-Oil Dispersions: the Oleopathic Hydro-Micelle , 1943, Nature.

[21]  O. Katare,et al.  Formulation, Characterization, and In Vitro Evaluation of Silymarin-Loaded Lipid Microspheres , 2004, Drug delivery.

[22]  M. Kushima,et al.  Alteration of therapeutic efficacy of lipid microspheres incorporating prostaglandin E1 by mixing with aqueous solution. , 2007, Journal of pharmaceutical sciences.

[23]  W. Schary,et al.  The Disposition and Bioavailability of Intravenous and Oral Nalbuphine in Healthy Volunteers , 1987, Journal of clinical pharmacology.

[24]  R. Pearce,et al.  Fluoropolymer-based Emulsions for the Intravenous Delivery of Sevoflurane , 2008, Anesthesiology.

[25]  S. Kawakami,et al.  Biodistribution Characteristics of Galactosylated Emulsions and Incorporated Probucol for Hepatocyte-Selective Targeting of Lipophilic Drugs in Mice , 2004, Pharmaceutical Research.

[26]  T. Mayumi,et al.  A nanometer lipid emulsion, lipid nano-sphere (LNS), as a parenteral drug carrier for passive drug targeting. , 2004, International journal of pharmaceutics.

[27]  P. Constantinides,et al.  Formulation Development and Antitumor Activity of a Filter-Sterilizable Emulsion of Paclitaxel , 2000, Pharmaceutical Research.

[28]  S. Benita.  Submicron Emulsions in Drug Targeting and Delivery , 2019 .

[29]  D. Gopinath,et al.  1-O-alkylglycerol stabilized carbamazepine intravenous o/w nanoemulsions for drug targeting in mice , 2007, Journal of drug targeting.

[30]  Xing Tang,et al.  Formulation and evaluation of nimodipine‐loaded lipid microspheres , 2006, The Journal of pharmacy and pharmacology.

[31]  Jin Liu,et al.  The Efficacy and Safety of Intravenous Emulsified Isoflurane in Rats , 2006, Anesthesia and analgesia.

[32]  S. Benita,et al.  Submicron emulsions as colloidal drug carriers for intravenous administration: comprehensive physicochemical characterization. , 1993, Journal of pharmaceutical sciences.

[33]  S. Kawakami,et al.  Biodistribution characteristics of mannosylated and fucosylated O/W emulsions in mice , 2005, Journal of drug targeting.

[34]  I. M. Shaikh,et al.  Applications of microemulsion based drug delivery system. , 2006, Current drug delivery.

[35]  S. Kawakami,et al.  Inhibition of liver metastasis by all-trans retinoic acid incorporated into O/W emulsions in mice. , 2006, International journal of pharmaceutics.

[36]  Jian Xu,et al.  Formation and stability of paraffin oil-in-water nano-emulsions prepared by the emulsion inversion point method. , 2006, Journal of colloid and interface science.

[37]  C. Solans,et al.  Nano-Emulsions: Formation, Properties, and Applications , 2003 .

[38]  I. Capek.  Degradation of kinetically-stable o/w emulsions. , 2004, Advances in colloid and interface science.

[39]  M. Malmsten,et al.  Physicochemical characterisation of a drug-containing phospholipid-stabilised o/w emulsion for intravenous administration. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[40]  R. Müller,et al.  Formulation of intravenous carbamazepine emulsions by SolEmuls technology. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[41]  Katsuya Tanaka,et al.  Intravenous Emulsified Halogenated Anesthetics Produce Acute and Delayed Preconditioning against Myocardial Infarction in Rabbits , 2004, Anesthesiology.

[42]  L. Deriemaeker,et al.  OSTWALD RIPENING OF ALKANE EMULSIONS IN THE PRESENCE OF SURFACTANT MICELLES , 1999 .

[43]  L. Obbergh,et al.  A second-generation blood substitute (perflubron emulsion) increases the blood solubility of modern volatile anesthetics in vitro. , 2002 .

[44]  M. Takasaki,et al.  Acute Pulmonary Edema After Intravenous Liquid Halothane in Dogs , 1992, Anesthesia and analgesia.

[45]  A. Tedesco,et al.  Binding and photophysical studies of biocompatible magnetic fluid in biological medium and development of magnetic nanoemulsion: A new candidate for cancer treatment , 2007 .

[46]  M. Lakomek,et al.  Transient and controllable opening of the blood-brain barrier to cytostatic and antibiotic agents by alkylglycerols in rats , 2000, Experimental Brain Research.

[47]  Polymeric Nanoparticles as Drug Carriers , 2006 .

[48]  K. Lowe,et al.  Novel compositions of emulsified perfluorochemicals for biological uses. , 1988, Biomaterials, artificial cells, and artificial organs.

[49]  P. Legrand,et al.  Surface-modified and conventional nanocapsules as novel formulations for parenteral delivery of halofantrine. , 2006, Journal of nanoscience and nanotechnology.

[50]  D. A. Saville,et al.  Colloidal Dispersions: ACKNOWLEDGEMENTS , 1989 .

[51]  Xing Tang,et al.  Formulation, preparation and evaluation of flunarizine‐loaded lipid microspheres , 2007, The Journal of pharmacy and pharmacology.

[52]  P. Kralchevsky,et al.  Flocculation of Deformable Emulsion Droplets: II. Interaction Energy , 1995 .

[53]  D. Driscoll,et al.  Lipid Injectable Emulsions: Pharmacopeial and Safety Issues , 2006, Pharmaceutical Research.

[54]  A. del Pozo,et al.  Use of ultrasound to prepare lipid emulsions of lorazepam for intravenous injection. , 2001, International journal of pharmaceutics.

[55]  C. Hung,et al.  Development and evaluation of emulsion-liposome blends for resveratrol delivery. , 2006, Journal of nanoscience and nanotechnology.

[56]  M. Lance,et al.  Structure and toxicity of amphotericin B/triglyceride emulsion formulations. , 1995, The Journal of antimicrobial chemotherapy.

[57]  Hiroshi Saito,et al.  The effect of temperature on the phase equilibria and the types of dispersions of the ternary system composed of water, cyclohexane, and nonionic surfactant , 1968 .

[58]  E. D. Shchukin,et al.  Ostwald ripening theory: applications to fluorocarbon emulsion stability , 1992 .

[59]  I. Lifshitz,et al.  The kinetics of precipitation from supersaturated solid solutions , 1961 .

[60]  S. Friberg,et al.  Emulsification and the HLB-temperature , 1978 .

[61]  D. Kyle,et al.  Pharmacokinetics, efficacy and toxicity of parenteral halofantrine in uncomplicated malaria. , 1993, British journal of clinical pharmacology.

[62]  S. Talegaonkar,et al.  Multiple emulsions: an overview. , 2006, Current drug delivery.

[63]  Jean G. Riess,et al.  Oxygen Carriers (“Blood Substitutes”)Raison d'Etre, Chemistry, and Some Physiology Blut ist ein ganz besondrer Saft1 , 2001 .

[64]  J. Riess,et al.  Understanding the Fundamentals of Perfluorocarbons and Perfluorocarbon Emulsions Relevant to In Vivo Oxygen Delivery , 2005, Artificial cells, blood substitutes, and immobilization biotechnology.

[65]  T. Tadros,et al.  Formation and stability of nano-emulsions. , 2004, Advances in colloid and interface science.

[66]  Chen Dawei,et al.  A less irritant norcantharidin lipid microspheres: formulation and drug distribution. , 2006, International journal of pharmaceutics.

[67]  and Alexey Kabalnov,et al.  Macroemulsion Stability: The Oriented Wedge Theory Revisited , 1996 .

[68]  H. Nakajima.  MICROEMULSIONS IN COSMETICS , 1997 .

[69]  M. El-Aasser.  2002 Roy W. Tess Award , 2004 .

[70]  M. Sznitowska,et al.  Submicron emulsions as drug carriers. Studies on destabilization potential of various drugs. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[71]  K. Buszello,et al.  Emulsions as Drug Delivery Systems , 2000 .

[72]  E. Sudoł,et al.  Miniemulsions: Overview of research and applications , 2004 .

[73]  S. Kawakami,et al.  Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated O/W emulsions by macrophages. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[74]  N. D. da Silveira,et al.  Physico-chemical characterization and in vivo evaluation of indomethacin ethyl ester-loaded nanocapsules by PCS, TEM, SAXS, interfacial alkaline hydrolysis and antiedematogenic activity. , 2006, Journal of nanoscience and nanotechnology.

[75]  Connie B. Chang,et al.  Nanoemulsions: formation, structure, and physical properties , 2006 .

[76]  Hong Wu,et al.  Preparation of poly(butylene-co-ε-caprolactone carbonate) and their use as drug carriers for a controlled delivery system , 2007 .

[77]  T. Sakaeda,et al.  Prolonged circulation of menatetrenone by emulsions with hydrogenated castor oils in rats. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[78]  B. Bhandari,et al.  Nano-Emulsion Production by Sonication and Microfluidization—A Comparison , 2006 .

[79]  K. Danov,et al.  Flocculation of Deformable Emulsion Droplets: I. Droplet Shape and Line Tension Effects , 1995 .

[80]  E. Lowenstein,et al.  An anesthetic accident: cardiovascular collapse from liquid halothane delivery. , 1969, Anesthesiology.

[81]  Ostwald ripening in emulsions , 1998 .

[82]  R. Müller,et al.  Intravenous itraconazole emulsions produced by SolEmuls technology. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[83]  M. J. García,et al.  Formation and Stability of Nano-Emulsions Prepared Using the Phase Inversion Temperature Method , 2002 .

[84]  B. MacLeod,et al.  Anaesthesia by intravenous emulsified isoflurane in mice , 1995, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[85]  Dipak K. Sarker.  Engineering of nanoemulsions for drug delivery. , 2005, Current drug delivery.

[86]  J. Weers,et al.  The effect of molecular diffusion on initial particle size distributions in phospholipid-stabilized fluorocarbon emulsions , 1994 .

[87]  E. Verwey,et al.  Theory of the stability of lyophobic colloids. , 1955, The Journal of physical and colloid chemistry.

[88]  J. Blais,et al.  A comparative study of the cellular uptake, localization and phototoxicity of meta-tetra(hydroxyphenyl) chlorin encapsulated in surface-modified submicronic oil/water carriers in HT29 tumor cells. , 2000, Journal of photochemistry and photobiology. B, Biology.

[89]  R. Müller,et al.  Solubilizing poorly soluble antimy cotic agents by emulsification via a solvenent-free process , 2004, AAPS PharmSciTech.

[90]  R. Hatcher.  THE UNITED STATES PHARMACOPEIA. , 1908 .

[91]  P. Legrand,et al.  Efficacy and Pharmacokinetics of Intravenous Nanocapsule Formulations of Halofantrine in Plasmodium berghei-Infected Mice , 2004, Antimicrobial Agents and Chemotherapy.

[92]  M. Galmozzi,et al.  The use of lipid emulsions for the i.v. administration of a new water soluble polyene antibiotic, SPK-843. , 2002, The Journal of antimicrobial chemotherapy.

[93]  K. Marsh,et al.  Falciparum malaria: differential effects of antimalarial drugs on ex vivo parasite viability during the critical early phase of therapy. , 1993, The American journal of tropical medicine and hygiene.

[94]  M. Alonso,et al.  Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.